For vaccine development, in silico model can accelerate the computer identification algorithm of the relevant protein candidates with improved expression immunogens.ДЄdvanced DNA sequencing and cellular, molecular and immunological methods provide a large number of vaccine-related data, which has led to an increase in the amount of data associated with vaccines and vaccinations. In the development of small molecules, in silico model is important in genome-wide analysis, comparative genomics, pathway analysis, virtual screening and target identification. The database collects information about experimentally verified vaccine and vaccine components and in silico models use computational methods to predict and design new vaccine and the components. In silico models and databases play different but complementary roles in vaccine design. Rational vaccine prediction is more reasonable than years ago because of the two progressive areas, vaccine database and in silico vaccine design models. With the advent of computer-aided informatics and high-throughput technologies, vaccine research has entered a new era. Creative Biolabs offers in silico service to predict and design new vaccine and vaccine components.Дatabases and in Silico Models for Vaccine Design In silico models help to understand infectious diseases and develop novel therapeutics to treat them. Therefore, the development of anti-infective drugs that target drug-resistant pathogens is very urgent. The efficacy of all known current anti-infective agents is affected by the drug resistant form of the pathogens. Infectious diseases caused by bacteria, viruses, fungi, and parasites cause millions of deaths worldwide every year. Biomaterial-based Implantable Cancer Vaccine.Ag-Fc Fusion Protein Vaccine for Cancer.MHC Class II-associated li Protein Suppression Technology.Antibody-antigen Fusion Technology for Cancer Vaccine.Microfluidic Cell-squeezing Technology for B Cell-based Vaccine.Cytokine Development to Enhance Antigen Presentation.Exosome-based Therapeutic Cancer Vaccines.Cytomegalovirus-based Cancer Immunotherapy.Fully Synthetic Carbohydrate Based Cancer Vaccines.Cutaneous Squamous Cell Carcinoma Vaccines.GMP-grade Antigen Production for Vaccine.Suspension Culture of Insect Cells for Subunit Vaccine Production.Suspension Culture for Rabies Vaccine Production.Suspension Culture for Porcine Parvovirus Vaccine Production.Suspension Culture for Newcastle Disease Vaccine Production.Suspension Culture for Avian Influenza Vaccine Production.Suspension Culture for PCV2 Vaccine Production.Suspension Culture for Pseudorabies Vaccine Production.Controlled Release Vaccines Development.Design of Experiment (DOE)-based Formulation Platform.SuperStableв„ў Thermostability Technology for Stable Storage of Vaccines.epiVacKit-Epitope-driven Vaccine Design Toolkit.Epitope Predicting Algorithm for Vaccine Design.Outer Membrane Vesicles (OMVs) Platform for Vaccine Design.Target-Ag В® Platform for Allergic Disease Vaccines.House Dust Mite Induced Allergic Asthma.Fluorescent Virus-Like Particles Production.mRNA Pharmacology Optimization Platform.Custom GMP-grade mRNA Synthesis Service.Self-amplifying mRNA (SAM) Vaccine Platform.

In silico method